MAY 06, 2018 8:03 PM PDT

Cannabis and the Relief for HIV/AIDS

WRITTEN BY: Melissa Moore

On Saturday, May 5, 2018, Buffalo, NY celebrated their 26th annual AIDS walk that brings awareness and honor to those who have lost the fight, and to those who suffer from the terminal disease.  In attendance was PharmaCannis dispensary sharing the knowledge on how cannabis can help patients suffering from the virus and from retrotherapy side effects.  

Cannabis relieves a myriad of symptoms brought on by the HIV/AIDS virus and also helps quell the side effects of the current Antiretroviral therapy. This therapy prevents the multiplication and spread of the virus throughout the body, but also has side effects ranging from nausea, bone loss, fatigue, insomnia, anxiety, and lipodystrophy.  Cannabis fights nausea, increases the activity of osteoblasts, can reduce fatique, insomnia, and anxiety, and can regulate the metabolism. 

It is seen that a significant amount of HIV/AIDS patients self-medicate with cannabis, this has encouraged multiple studies to be performed with cannabis and HIV patients. In 2008 a phase II, double-blind, placebo-controlled, crossover trial of analgesia with smoked cannabis in HIV-associated distal sensory predominant polyneuropathy (DSPN) was completed. Results show that pain relief is greater with cannabis than with the placebo.  Mood and daily functioning improved to a similar extent during both treatment periods.  In this randomized clinical trial, smoked cannabis at maximum tolerable dose (1–8% THC), significantly reduced neuropathic pain intensity in HIV-associated DSPN compared to placebo, when added to stable concomitant analgesics. Using verbal descriptors of pain magnitude from DDS, cannabis was associated with an average reduction of pain intensity from ‘strong’ to ‘mild to moderate.’ Also, cannabis was associated with a sizeable (46%) and significantly greater (vs. 18% for placebo) proportion of patients who achieved meaningful pain relief. Mood disturbance, physical disability, and quality of life all improved significantly for subjects during study treatments, regardless of treatment order.

A study published in 2014 titled "Modulation of Gut-Specific Mechanisms by Chronic Delta 9-Tetrahydrocannabinol Administration in Male Rhesus Macaques Infected with Simian Immunodeficiency Virus: A Systems Biology Analysis"  This seventeen month study reviewed the effects THC had on monkeys infected with an animal form of the virus. Scientists found that damage to immune tissue was decreased.  “These findings reveal novel mechanisms that may potentially contribute to cannabinoid-mediated disease modulation,” Dr. Patricia Molina, the study’s lead author, wrote. The report goes on to explain that while HIV spreads by infecting and killing off immune cells, the monkeys that received the daily THC treatments maintained higher levels of healthy cells.

A more recent study publishd in the Journal of Acquired Immune Deficiency Syndrome (JAIDS), found that THC might be able to prevent HIV from becoming full-blown AIDS.  A consequence of Human Immunodeficiency Virus-1 (HIV) infection is a decrease in both pDC  (Plasmacytoid dendritic cell) number and function, but prolonged pDC activity has been linked with progression from HIV infection to the development of AIDS.  THC can suppress pDC function during the early host antiviral response by dampening pDC activation; this prevents the condition from worsening.  Not only may patients reduce their symptoms of side effects from this terminal illness, but cannabis may also help prolong or save their lives. 

 

Sources: neuropsychopharmacology, Simian Immunodeficiency Virus, Plasmacytoid dendritic cells, youtube

About the Author
  • Currently working with Pharmacannis, a dispensary in Buffalo, NY. Resided in Northern California for the past 15 years working in the cannabis industry as a farmer, breeder, and chemical analyst. Received a bachelor's degree in biology at Keuka College in NY. Studied nursing at Mendocino College in CA, and currently attending University at Buffalo for a Master's of Education in Science and the Public. I have a passion for research with a focus in the field of endocannabinology.
You May Also Like
NOV 22, 2020
Cannabis Sciences
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
NOV 22, 2020
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
Researchers from St. Michael’s Hospital in Toronto have found that two synthetic cannabinoids available on prescri ...
JAN 28, 2021
Health & Medicine
Cannabis Use Disorder in Youths Linked With Self-Harm and Mortality Risk
JAN 28, 2021
Cannabis Use Disorder in Youths Linked With Self-Harm and Mortality Risk
Cannabis use disorder or CUD is common among younger cannabis users with mood disorders such as bipolar disorder or majo ...
FEB 04, 2021
Health & Medicine
Swish and Swallow Cannabis Treatment for COVID?
FEB 04, 2021
Swish and Swallow Cannabis Treatment for COVID?
Swish and Swallow COVID Treatment? Might a mouthwash help combat Coronavirus? It’s a question that cannabis resear ...
MAR 18, 2021
Cannabis Sciences
Migraine Sufferers Who Use Cannabis Have More Headaches
MAR 18, 2021
Migraine Sufferers Who Use Cannabis Have More Headaches
Researchers from Stanford University School of Medicine have found that people who use cannabis for pain relief from chr ...
APR 10, 2021
Cannabis Sciences
Cannabis Users Exercise More than Nonusers
APR 10, 2021
Cannabis Users Exercise More than Nonusers
The rate of cannabis use among American adults tripled between 2003 and 2018 from 4.1% to 15.9%. During this time, some ...
MAY 08, 2021
Coronavirus
Surveys Suggest Cannabis Users Looking for Some Pandemic Happiness
MAY 08, 2021
Surveys Suggest Cannabis Users Looking for Some Pandemic Happiness
Two recent, separately published surveys combine to create an interesting overview of how cannabis use changed duri ...
Loading Comments...